Wojtecka-Lukasik, E <br/><br/>
Anti-inflammatory drugs modulate histamine release from mast cells induced by fibrinogen degradation products.  [electronic resource] 

 -  Annals of the rheumatic diseases  Apr 1988 
 - 328-32 p.  digital 
<br/><br/> Publication Type: Journal Article 
<br/><br/><label>ISSN: </label>0003-4967 
<br/><br/><label>Standard No.: </label>10.1136/ard.47.4.328  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>4,5-Dihydro-1-(3-(trifluoromethyl)phenyl)-1H-pyrazol-3-amine<br/>Acetylcarnitine<br/>Animals<br/>Anti-Inflammatory Agents--pharmacology<br/>Anti-Inflammatory Agents, Non-Steroidal--pharmacology<br/>Aspirin--pharmacology<br/>Auranofin--pharmacology<br/>Cells, Cultured<br/>Dose-Response Relationship, Drug<br/>Fibrin Fibrinogen Degradation Products--metabolism<br/>Guanidines--pharmacology<br/>Histamine Release--drug effects<br/>Male<br/>Mast Cells--drug effects<br/>Naproxen--pharmacology<br/>Pyrazoles--pharmacology<br/>Rats<br/>Rats, Inbred Strains